| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥314.9B | ¥173.3B | +81.7% |
| Operating Income | ¥62.6B | ¥17.6B | +256.6% |
| Ordinary Income | ¥62.1B | ¥17.1B | +264.2% |
| Net Income | ¥43.1B | ¥11.9B | +263.3% |
| ROE | 27.8% | 10.0% | - |
FY2026 Q3 consolidated results showed exceptional performance driven by antimony market dynamics. Revenue reached ¥31.49B (YoY +81.7%), Operating Income ¥6.26B (+256.6%), Ordinary Income ¥6.21B (+264.2%), and Net Income ¥4.31B (+263.3%). The dramatic profit expansion was primarily attributable to antimony ingot prices surging approximately 104% YoY due to Chinese export control measures, resulting in a record quarterly operating margin of 19.9%. ROE reached 27.8% on a DuPont basis. However, management maintains conservative full-year guidance at ¥40.2B revenue and ¥5.3B operating income, anticipating significant inventory valuation losses in Q4 as antimony prices have declined sharply from peak levels of approximately 35,000/ton by December 2025, with further decline to low-$20,000s expected by fiscal year-end.
Revenue growth of 81.7% was entirely driven by the Antimony Products segment, where sales increased 138.0% to ¥23.65B despite a 15.5% volume decline to 2,967 tons. The price effect from antimony ingot averaging $44,200/ton in Q3 (up 104% YoY) more than offset volume contraction. Additional positive contribution came from inventory valuation gains as rising prices throughout the period increased asset values on the balance sheet.
Operating income expansion of 256.6% reflected exceptional operating leverage in the Antimony business, where segment profit surged 362.0% to ¥5.90B despite lower volumes. The cost structure benefited from price pass-through exceeding raw material cost increases, resulting in gross margin expansion to 23.4%. Selling, general and administrative expenses were held relatively flat, growing slower than revenue and contributing to operating margin improvement from 10.1% to 19.9%.
The Atomized Metal Powders segment presented a contrasting picture, with sales growing modestly 6.0% to ¥7.86B primarily due to higher silver prices, but volumes declining 11.3% to 1,650 tons. Segment profit decreased 26.0% to ¥0.33B as lower production volumes resulted in manufacturing inefficiencies and operating deleverage. Competitive intensity in electronics applications and weak automotive component demand, particularly powder metallurgy applications, pressured both volume and margin.
Ordinary income of ¥6.21B was essentially aligned with operating income, with non-operating items netting to a minor ¥0.42B loss. This included foreign exchange losses of ¥0.19B and interest expense of ¥0.60B, offset by minor gains. The absence of material non-operating gains indicates the operating profit expansion was driven by core business performance rather than extraordinary items.
Net income of ¥4.31B reflected an effective tax rate of approximately 30.5%, within normal corporate tax parameters, confirming the quality of pre-tax earnings. The significant gap between operating income (¥6.26B) and net income (¥4.31B) is attributable to ordinary tax burden rather than non-recurring items.
This represents a revenue up/profit up pattern, with profit growth substantially exceeding revenue growth due to extraordinary price leverage in the core Antimony segment. However, the sustainability of this pattern is questionable given the non-recurring nature of the antimony price spike and anticipated Q4 reversal.
Antimony Products is the core business, contributing 74.9% of total revenue and 94.3% of total segment operating profit. This segment delivered ¥23.65B in sales (up 138.0% YoY) and ¥5.90B in operating profit (up 362.0% YoY), achieving an exceptional operating margin of 24.9%. Sales volume decreased 15.5% to 2,967 tons, but the average antimony ingot price of approximately $44,200/ton (up 104% YoY) drove the revenue expansion. The margin expansion from 12.8% in prior year to 24.9% reflects both price pass-through and inventory valuation effects. This segment was the sole driver of consolidated profit growth.
Atomized Metal Powders contributed ¥7.86B in sales (up 6.0% YoY) and ¥0.33B in operating profit (down 26.0% YoY), with operating margin contracting from 5.8% to 4.3%. Volume declined 11.3% to 1,650 tons despite higher silver prices supporting revenue. The margin compression resulted from reduced production volumes creating manufacturing inefficiencies, combined with intensifying competition in electronics and powder metallurgy applications. Weak automotive component demand, particularly in powder metallurgy end-markets, pressured volumes. The segment's contribution to consolidated profit declined from 21.8% to 5.7%.
The material margin differential between segments (24.9% for Antimony vs. 4.3% for Metal Powders) reflects both the extraordinary antimony price environment and the structural challenges facing the Metal Powders business including commoditization pressure and demand weakness in key end-markets.
Profitability: ROE 27.8% (substantially above typical levels, driven by extraordinary antimony pricing), Operating Margin 19.9% (up from 10.1% prior year), Net Profit Margin 13.7% (up from 6.9% prior year), Gross Margin 23.4%. The DuPont decomposition shows ROE driven by Net Profit Margin 13.7%, Asset Turnover 1.315, and Financial Leverage 1.54x.
Efficiency: Total Asset Turnover 1.315 indicates efficient asset utilization relative to revenue generation. Working capital metrics show areas requiring attention: Receivables Turnover 61 days (suggesting collection delays), Inventory Turnover 78 days (inventory build relative to sales pace), Cash Conversion Cycle 164 days (extended working capital cycle).
Financial Health: Equity Ratio 64.9% (up from 57.0%, indicating strengthened capital structure), Current Ratio 275.0% (strong liquidity), Quick Ratio 194.8% (robust short-term solvency excluding inventory). Cash to short-term liabilities ratio of 2.01x provides substantial payment capacity.
Leverage: Total debt ¥2.99B, Debt-to-Capital 16.1% (conservative capital structure), Interest Coverage approximately 104x (minimal interest burden with ¥0.60B interest expense against ¥6.26B operating income).
Investment Activity: CapEx and Depreciation & Amortization figures not disclosed in available data, limiting assessment of capital intensity and reinvestment rate.
Shareholder Returns: ROE of 27.8% substantially exceeds cost of equity, though the sustainability of this level is questionable given anticipated Q4 inventory losses.
Operating Cash Flow data was not disclosed in the quarterly results, preventing direct assessment of cash earnings quality and the operating CF to net income ratio. This represents a significant limitation in evaluating whether the ¥4.31B net income is being converted to cash.
Indirect cash flow indicators from balance sheet changes show cash and deposits increased ¥1.44B (66.7%) to ¥3.55B, suggesting positive cash generation during the period. However, the source of this cash increase cannot be confirmed without operating CF disclosure—it could reflect operating performance, borrowing activity, or asset disposals.
Investing Cash Flow activities are not explicitly disclosed. Capital expenditure levels are unknown, preventing calculation of Free Cash Flow or assessment of growth investment intensity.
Financing Cash Flow changes can be partially inferred from balance sheet movements: short-term borrowings decreased ¥1.20B (40.6%) to ¥1.76B while long-term debt increased ¥0.50B (68.7%) to ¥1.23B, indicating refinancing from short-term to long-term debt structure. This maturity extension improves refinancing risk profile. Dividends paid during the nine-month period totaled ¥0.70B.
Free Cash Flow cannot be calculated without operating CF and capex disclosure.
Working capital absorption is evident from balance sheet changes: inventory increased ¥1.34B (35.1%) to ¥5.17B, growing faster than the 81.7% revenue growth and indicating potential inventory build or valuation effects from rising antimony prices during the quarter. Trade receivables increased modestly in line with sales growth. The inventory build, combined with the anticipated Q4 antimony price decline, creates risk of significant inventory valuation losses that would represent non-cash charges against earnings.
Cash generation assessment: While cash balances increased and the company maintains strong liquidity ratios, the absence of operating CF disclosure and the concerning working capital trends (particularly inventory accumulation ahead of anticipated price declines) warrant a "Needs Monitoring" designation for cash generation quality. The 164-day cash conversion cycle indicates room for working capital efficiency improvement.
Ordinary Income of ¥6.21B and Net Income of ¥4.31B show a 31% differential, which is primarily attributable to income tax expense at an effective rate of approximately 30.5%. This tax rate is within normal corporate parameters and does not indicate earnings quality concerns. Non-operating expenses totaled ¥0.42B, including interest expense of ¥0.60B and foreign exchange losses of ¥0.19B, offset by minor gains. These amounts are immaterial relative to operating income (less than 7% of operating income) and do not represent significant earnings manipulation or one-time items.
However, significant earnings quality concerns arise from the antimony price dynamics and inventory valuation effects. The Q3 results benefited from inventory valuation gains as antimony prices rose during the quarter, but management explicitly warns of substantial inventory valuation losses expected in Q4 as prices have declined sharply. The Antimony segment is forecast to generate an operating loss of ¥1.10B in Q4 specifically due to inventory valuation losses. While inventory gains and losses are technically "operating" items that flow through cost of sales, their volatility and non-recurring nature mean the Q3 operating margin of 19.9% and segment margin of 24.9% in Antimony Products substantially overstate sustainable profitability.
The absence of Operating Cash Flow disclosure prevents assessment of whether reported earnings are being converted to cash—a critical earnings quality indicator. The combination of (1) significant profit expansion, (2) 35.1% inventory build, and (3) no operating CF disclosure raises concerns about potential accrual-based earnings that may not reflect cash generation. The 164-day cash conversion cycle and working capital absorption suggested by inventory growth indicate potential divergence between reported profits and cash realization.
Adjusting for non-recurring elements: The ¥6.26B operating income includes estimated inventory valuation gains (magnitude not disclosed) that will reverse in Q4. Management's full-year operating income guidance of ¥5.3B implies Q4 operating profit of approximately ¥-0.73B (calculated as ¥5.3B full-year minus ¥6.03B year-to-date through Q3), suggesting the recurring run-rate operating profit excluding inventory effects is substantially lower than the Q3 reported level. A normalized operating margin would likely be in the mid-to-high single digits rather than the reported 19.9%.
Core recurring earnings quality appears moderate, with the Antimony business benefiting from structurally elevated (though declining) antimony prices due to Chinese export controls, while the Metal Powders business faces structural headwinds from competition and weak end-market demand. The sustainability of the antimony price premium beyond the current regulatory environment is uncertain.
Full-year guidance remains unchanged at ¥40.2B revenue, ¥5.3B operating income, ¥5.2B ordinary income, and ¥3.55B net income, with annual dividend of ¥170 per share. Management last updated this guidance on September 24, 2024.
Progress rate versus full-year guidance: Through Q3 (nine months), revenue of ¥31.49B represents 78.3% of full-year target, operating income of ¥6.26B represents 118.1% of target, ordinary income of ¥6.21B represents 119.4% of target, and net income of ¥4.31B represents 121.4% of target.
The revenue progress of 78.3% is slightly ahead of the standard 75% nine-month benchmark, suggesting modest upside risk to revenue guidance. However, profit metrics at 118-121% of full-year targets indicate substantial Q4 deterioration is anticipated. The implied Q4 results are: revenue ¥8.71B (down 72.3% from Q3's ¥31.49B), operating income ¥-0.73B (loss versus Q3 profit of ¥6.26B), and net income ¥-0.76B (loss versus Q3 profit of ¥4.31B).
The dramatic implied Q4 decline reflects management's explicit expectation of large inventory valuation losses as antimony ingot prices are forecast to decline from Q3 average of 27,000/ton (down 38.9%). Antimony prices peaked at approximately 35,000/ton by December 2024, and are expected to fall to low-$20,000s by March 2025 fiscal year-end. The Antimony segment specifically is forecast to generate an ¥11.02B operating loss in Q4 due to these inventory valuation losses.
Guidance philosophy: Management has adopted an explicitly conservative stance by maintaining guidance despite substantial year-to-date outperformance. The presentation materials state the company is "striving to maintain appropriate inventory levels and minimize inventory valuation losses" but conservative assumptions reflect uncertainty around the magnitude of Q4 write-downs. This approach suggests management prioritizes avoiding negative surprises over providing aggressive targets, which is appropriate given the extraordinary price volatility.
The unchanged guidance despite strong Q3 performance indicates management has high confidence in the anticipated Q4 deterioration scenario. Investors should focus on (1) the actual magnitude of Q4 inventory losses relative to the implied ¥11B segment loss forecast, (2) antimony price stabilization levels, and (3) whether volume declines in both segments stabilize or accelerate.
Annual dividend is forecast at ¥170 per share for the full fiscal year, consisting of ¥60 interim dividend (already paid) and ¥140 year-end dividend (forecast). Based on 24.48 million shares outstanding and full-year net income guidance of ¥3.55B, the dividend payout ratio is approximately 117.2% (¥4.16B total dividends divided by ¥3.55B net income).
However, this calculation based on full-year guidance is distorted by the anticipated Q4 inventory loss. Using actual nine-month net income of ¥4.31B, the nine-month dividend of ¥0.70B (¥60 per share interim dividend × 24.48M shares, adjusted to actual payment) represents a payout ratio of approximately 16.2%, which is more representative of the underlying dividend policy.
The ¥170 per share annual dividend represents continuation from prior year levels, indicating management's commitment to dividend stability despite earnings volatility. Dividend sustainability appears secure given: (1) strong cash position of ¥3.55B (up 66.7%), (2) conservative debt levels with only ¥2.99B total debt, (3) robust equity base of ¥15.54B, and (4) the temporary nature of anticipated Q4 losses. The calculated payout ratio of 12.1% based on Q3 trailing net income indicates substantial dividend coverage.
No share buyback activity was disclosed in the quarterly materials.
Total shareholder return policy: Based on available information, the company appears focused on stable dividends rather than variable returns tied to earnings fluctuations. The maintained ¥170 dividend despite anticipated full-year earnings decline to ¥3.55B (versus prior year ¥11.9B) demonstrates this stability commitment. However, in years of extraordinary earnings like the current nine-month period, the stable dividend policy results in a low payout ratio of approximately 16%, suggesting potential for special dividends or buybacks that management has not pursued.
Free cash flow coverage of dividends cannot be assessed due to lack of operating cash flow and capex disclosure, though the strong balance sheet and cash increase suggest dividends are well-supported.
Near-term catalysts (next 6-12 months):
Long-term catalysts (1-3 years):
Industry Position (Reference - Proprietary Analysis)
Profitability: ROE 27.8% substantially exceeds manufacturing industry median of 5.0% (2025-Q3, n=98 companies), ranking in the top percentile. However, this exceptional performance is driven by non-recurring antimony price effects and is not representative of sustainable profitability. Operating Margin 19.9% significantly exceeds industry median of 8.3% (IQR: 4.8%-12.6%), again reflecting temporary antimony pricing. Net Profit Margin 13.7% is more than double the industry median of 6.3% (IQR: 3.2%-9.0%). The company's historical operating margin prior to the antimony price surge was approximately 10%, closer to industry norms.
Financial Health: Equity Ratio 64.9% is slightly above industry median of 63.8% (IQR: 49.5%-74.7%), indicating comparable financial stability. Current Ratio 275.0% is approximately aligned with industry median of 2.84x (IQR: 2.10x-3.81x), suggesting typical liquidity positioning for the manufacturing sector.
Efficiency: Asset Turnover 1.315 significantly exceeds industry median of 0.58 (IQR: 0.42-0.66), indicating superior asset efficiency. This likely reflects the relatively asset-light nature of the antimony and metal powder businesses compared to heavier manufacturing industries. However, Inventory Turnover of 78 days is better than industry median of 108.81 days (IQR: 49.60-154.77), though the inventory build trend noted in balance sheet analysis suggests potential deterioration. Receivables Turnover of 61 days is better than industry median of 82.87 days (IQR: 68.43-115.00).
Growth: Revenue Growth YoY of 81.7% dramatically exceeds industry median of 2.7% (IQR: -1.9%-7.9%), but this is entirely attributable to antimony price effects rather than volume expansion or market share gains, as actual volumes declined across both segments.
Leverage: The company's Financial Leverage of 1.54x is essentially aligned with industry median of 1.53 (IQR: 1.31-1.85), reflecting comparable capital structure conservatism.
Note: Industry benchmarks are from manufacturing sector (n=98 companies) for 2025-Q3 period. Source: Proprietary analysis of publicly available financial data. The company's current profitability metrics are highly distorted by commodity price effects and should not be interpreted as sustainable competitive advantages versus industry peers.
Commodity Price Exposure - Antimony Market Volatility: The core Antimony Products business (74.9% of revenue, 94.3% of segment profit) faces extreme price volatility, with international antimony ingot prices declining from peak of approximately 35,000/ton by December 2024, and forecast to reach low-10,000/ton change in antimony prices affects quarterly segment profit by an estimated ¥2-3B based on typical inventory levels and sales volumes.
Working Capital and Inventory Management Risk: Inventory increased 35.1% to ¥5.17B while sales volumes decreased across both segments (Antimony -15.5%, Metal Powders -11.3%), creating a concerning divergence between physical activity and balance sheet growth. The 78-day inventory turnover, while better than industry median, has deteriorated from prior periods. Cash Conversion Cycle of 164 days indicates extended working capital requirements. The absence of Operating Cash Flow disclosure prevents verification that reported profits are converting to cash. With antimony prices declining sharply in Q4, the elevated inventory position creates acute valuation loss risk. The company's stated focus on "maintaining appropriate inventory levels" suggests ongoing challenges in matching inventory to demand. Quantified impact: The 35.1% inventory increase represents ¥1.34B of incremental working capital absorption; if antimony prices decline an additional 30% in Q4 as forecast, this could generate ¥0.8-1.2B of additional valuation losses beyond current guidance assumptions.
Metal Powders Structural Decline and Volume Risk: The Atomized Metal Powders segment faces volume contraction (down 11.3% in Q3), operating margin compression (from 5.8% to 4.3%), and weak end-market fundamentals including intensifying competition in electronics applications, challenged automotive component demand particularly in powder metallurgy applications, and price-based competition from Chinese OEM suppliers. Management's commentary indicates these are structural rather than cyclical challenges, referencing "overall weak manufacturing sector trends" and "procurement difficulties from China and other OEM sources." While this segment represents only 24.9% of revenue and 5.7% of segment profit currently, it previously contributed over 20% of profit and represents diversification from antimony concentration. Continued deterioration could reduce the segment to breakeven or losses. Quantified impact: Segment profit declined ¥0.12B YoY; if volume declines continue at the current 11% annual rate without margin recovery, the segment could face ¥0.2-0.3B annual profit erosion.
Key Takeaway 1 - Extraordinary Current Profitability is Non-Recurring and Reversal is Imminent: The Q3 results showing 19.9% operating margin, 27.8% ROE, and ¥6.26B operating income represent peak profitability driven by antimony prices that have already declined significantly and are forecast to fall further. Management's unchanged full-year guidance implying Q4 operating loss of ¥0.73B and Antimony segment loss of ¥11.02B indicates high confidence in near-term deterioration. The earnings pattern represents a temporary commodity price spike rather than sustainable business improvement, evidenced by volume declines across both segments despite revenue growth. Investors should focus on normalized earnings power in a ¥25,000-30,000/ton antimony price environment (versus Q3's $44,200/ton), which would likely generate operating margins in the high single digits and ROE in the 8-12% range based on historical performance and segment economics. The company's conservative guidance approach and explicit warnings about Q4 inventory losses demonstrate appropriate transparency about earnings quality.
Key Takeaway 2 - Financial Foundation Remains Solid Despite Earnings Volatility: The company has strengthened its balance sheet through the period of elevated antimony prices, with equity ratio improving to 64.9%, cash increasing 66.7% to ¥3.55B, and debt refinancing from short-term to long-term structure (short-term borrowings down 40.6%, long-term debt up 68.7%). Current ratio of 275% and quick ratio of 195% provide substantial liquidity cushion to absorb the anticipated Q4 losses. The conservative 16% dividend payout ratio based on nine-month earnings and maintained ¥170 annual dividend despite anticipated full-year earnings decline demonstrate financial flexibility. Interest coverage of approximately 104x indicates minimal leverage risk. The 64.9% equity ratio and ¥15.54B total equity base provide capacity to weather commodity cycles and invest in business improvements. This financial strength contrasts with the earnings volatility and provides downside protection.
Key Takeaway 3 - Working Capital Efficiency and Cash Flow Transparency Require Monitoring: The 35.1% inventory increase despite volume declines, 164-day cash conversion cycle, and absence of operating cash flow disclosure create uncertainty about the quality of reported earnings and cash generation capacity. While cash balances increased, the source cannot be verified without operating CF data. The inventory build ahead of significant price declines represents either a timing mismatch or inventory management challenges that will materialize as Q4 valuation losses. Receivables turnover of 61 days flags potential collection delays. These working capital trends suggest the business may require significant capital to support operations even at lower activity levels, potentially constraining returns and cash available for shareholders. Future quarters should be evaluated based on: (1) disclosure of operating cash flow and reconciliation to reported earnings, (2) inventory reduction and improvement in turnover metrics, and (3) cash conversion cycle improvement toward industry benchmarks. The combination of commodity price exposure and working capital intensity creates a business profile that may generate volatile cash flows even when revenues stabilize.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
In the third quarter of the fiscal year ending March 2026 for Nihon Seiko Co., Ltd., antimony ingot prices surged due to tighter export controls by Chinese authorities, driving the Antimony Business to a record-high sales performance. Consolidated net sales rose 81.7% year on year to 314.90 billion yen, operating profit increased 256.7% to 62.63 billion yen, and net profit rose 263.3% to 43.14 billion yen, delivering substantial growth in both revenue and earnings and marking an all-time high for a third quarter. The Metal Powder Business also posted higher revenue as silver powder selling prices increased on the back of soaring silver prices. Meanwhile, sales volumes declined in both businesses, indicating that performance improvement was primarily price-driven. For the fourth quarter, as antimony ingot prices are on a sharp downward trend and there is a possibility of significant inventory valuation losses, the full-year outlook has been left unchanged.
Antimony Business sales rose 138.0% year on year to a record-high 236.52 billion yen, with segment profit reaching 59.02 billion yen, up 362.0%. Average antimony ingot prices rose approximately 104% year on year, leading to a substantial increase in selling prices. Metal Powder Business posted a 6.0% increase in sales to 78.09 billion yen, while segment profit fell 26.0% to 3.34 billion yen, resulting in higher revenue but lower earnings. The three-month average antimony ingot price in the third quarter fell 22% in USD terms versus the second quarter, with the decline expected to continue into the fourth quarter. Given the potential for significant inventory valuation losses in the fourth quarter, the full-year outlook remains unchanged from the forecast announced on September 24, 2025.
The antimony ingot market price declined from around 61,000 dollars at the July 2025 peak to around 35,000 dollars at end-December, and is projected to reach the low 20,000-dollar range by the end of March 2026. There is a high likelihood of substantial inventory valuation losses in the fourth quarter due to falling ingot prices. In the Metal Powder Business, intensified competition is expected in electronic components for low-end smartphones and automotive-related markets, and subdued demand for powder metallurgy automotive parts is likely to persist. The company will strive to maintain appropriate inventory levels to minimize valuation losses.
The full-year consolidated outlook is maintained at net sales of 402.0 billion yen, operating profit of 53.0 billion yen, and net profit of 35.5 billion yen. Fourth-quarter assumptions are an antimony ingot price of 27,000 dollars/ton, copper at 1,480 yen/kg, and an exchange rate of 145 yen/dollar. For the fourth quarter, the Antimony Business is expected to post sales of 58.48 billion yen and a segment loss of 11.02 billion yen. Management acknowledges the risk of inventory valuation losses and indicates a stance of minimizing the impact by maintaining appropriate inventory levels.
Maximize earnings by appropriately passing through selling prices in response to surging antimony ingot prices. Establish procurement and sales frameworks aligned with tighter export controls by Chinese authorities. Improve profitability in the Metal Powder Business through production efficiency gains and higher operating rates. Curb the occurrence of inventory valuation losses by maintaining appropriate inventory levels. Diversify sales channels and stabilize OEM procurement amid a generally soft operating environment in manufacturing.
Risk of significant inventory valuation losses due to a sharp decline in antimony ingot prices (high likelihood of materialization in the fourth quarter). Risk of reduced sales volumes due to difficulties in procuring OEM products from countries such as China. Risk of demand contraction due to the generally sluggish trend in the manufacturing sector. Risk of intensified competition in the electronic components market and continued weakness in demand for automotive parts in the Metal Powder Business. Risk of impact on profitability in the Metal Powder Business from fluctuations in silver and copper prices.